354 related articles for article (PubMed ID: 8720305)
1. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.
Hey JA; del Prado M; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):159-63. PubMed ID: 8720305
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
[TBL] [Abstract][Full Text] [Related]
3. Some observations on the cardiotoxic and drug interaction profiles of second generation antihistamines as measured in the guinea pig.
Roberts DJ; Llenas J
Arzneimittelforschung; 1996 Aug; 46(8):832-3. PubMed ID: 9125289
[No Abstract] [Full Text] [Related]
4. The guinea pig model for assessing cardiotoxic proclivities of second generation antihistamines.
Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Aug; 46(8):834-7. PubMed ID: 9125290
[No Abstract] [Full Text] [Related]
5. Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonists: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea-pigs.
Hey JA; Del Prado M; Cuss FM; Egan RW; Sherwood J; Lin CC; Kreutner W
Clin Exp Allergy; 1995 Oct; 25(10):974-84. PubMed ID: 8556569
[TBL] [Abstract][Full Text] [Related]
6. Effects of H1 antihistamines on animal models of QTc prolongation.
Gras J; Llenas J
Drug Saf; 1999; 21 Suppl 1():39-44; discussion 81-7. PubMed ID: 10597867
[TBL] [Abstract][Full Text] [Related]
7. The role of ketoconazole in the QTc interval prolonging effects of H1-antihistamines in a guinea-pig model of arrhythmogenicity.
Gras J; Llenas J; Palacios JM; Roberts DJ
Br J Pharmacol; 1996 Sep; 119(2):187-8. PubMed ID: 8886395
[TBL] [Abstract][Full Text] [Related]
8. [The effect of second generation histamine antagonists on the heart].
Grzelewska-Rzymowska I; Pietrzkowicz M; Górska M
Pneumonol Alergol Pol; 2001; 69(3-4):217-26. PubMed ID: 11575008
[TBL] [Abstract][Full Text] [Related]
9. Cardiac effects of ebastine and other antihistamines in humans.
Moss AJ; Morganroth J
Drug Saf; 1999; 21 Suppl 1():69-80; discussion 81-7. PubMed ID: 10597870
[TBL] [Abstract][Full Text] [Related]
10. Terfenadine, astemizole, and ebastine produce QTc interval prolongation in an experimental model predictive of adverse clinical ECG effects.
Hey JA; del Prado M; Egan RW; Kreutner W
Ann Allergy Asthma Immunol; 1996 May; 76(5):476. PubMed ID: 8630724
[No Abstract] [Full Text] [Related]
11. Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.
Chaikin P; Gillen MS; Malik M; Pentikis H; Rhodes GR; Roberts DJ
Br J Clin Pharmacol; 2005 Mar; 59(3):346-54. PubMed ID: 15752381
[TBL] [Abstract][Full Text] [Related]
12. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE
Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
[TBL] [Abstract][Full Text] [Related]
13. A review of the cardiac systemic side-effects of antihistamines: ebastine.
Moss AJ; Chaikin P; Garcia JD; Gillen M; Roberts DJ; Morganroth J
Clin Exp Allergy; 1999 Jul; 29 Suppl 3():200-5. PubMed ID: 10444238
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular toxicity of antihistamines.
Smith SJ
Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 2):348-54. PubMed ID: 7916150
[TBL] [Abstract][Full Text] [Related]
15. Second-generation antihistamines: the risk of ventricular arrhythmias.
DuBuske LM
Clin Ther; 1999 Feb; 21(2):281-95. PubMed ID: 10211532
[TBL] [Abstract][Full Text] [Related]
16. Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models.
Llupià J; Gras J; Llenas J
Arzneimittelforschung; 2003; 53(2):93-7. PubMed ID: 12642964
[TBL] [Abstract][Full Text] [Related]
17. Towards the optimal antihistamine: studies with ebastine.
Roberts DJ
Inflamm Res; 1998; 47 Suppl 1():S36-7. PubMed ID: 9561405
[No Abstract] [Full Text] [Related]
18. Pharmacokinetic overview of oral second-generation H1 antihistamines.
González MA; Estes KS
Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
[TBL] [Abstract][Full Text] [Related]
19. Preclinical in vitro cardiac electrophysiology: a method of predicting arrhythmogenic potential of antihistamines in humans?
Cavero I; Mestre M; Guillon JM; Heuillet E; Roach AG
Drug Saf; 1999; 21 Suppl 1():19-31; discussion 81-7. PubMed ID: 10597865
[TBL] [Abstract][Full Text] [Related]
20. Variability of the QTc interval: impact on defining drug effect and low-frequency cardiac event.
Morganroth J; Brown AM; Critz S; Crumb WJ; Kunze DL; Lacerda AE; Lopez H
Am J Cardiol; 1993 Aug; 72(6):26B-31B. PubMed ID: 8256752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
